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EDITORIAL REVIEW
Recent advances in the biochemistry of glomerular
basement membrane
Basement membranes are abundant, sheet—like protein ma-
trices which compartmentalize many tissues and organs in the
body. They are considered to be important for maintaining
tissue integrity, to play a role in embryonic development and
tissue repair, and to serve as barriers for cell movement and the
filtration of macromolecules [1, 2]. The latter function is par-
ticularly obvious for the glomerular basement membrane
(GBM), which acts as an ultrafiltration unit between the capil-
lary and urinary (Bowman's) space within the renal glomerulus
[31. The GBM differs from other basement membranes in a few
features [2, 31. It consists of a rather thick, electron—dense
central layer (lamina densa, diameter 50 to 100 nm) which is
bordered on each side by an electron—lucent lamina rara (diam-
eter 20 to 50 nm). Studies of the origin of GBM during
embryogenesis [41 show that it is synthesized by both
endothelial cells sitting at the capillary site and epithelial—like
podocytes which are anchored to the urinary site. The (jBM
lacks a lamina reticularis which anchors many other basement
membranes to interstitial connective tissue. At many sites
(endothelial fenestrae, filtration slits), the GBM is directly
exposed to body fluids or connected to an intracapillary mesan-
gial matrix. This matrix has a basement membrane—like com-
position and contains mesangial cells which are involved in
phagocytosis and the regulation of intraglomerular hemody-
namics [31.
The unique morphology of GBM is, however, apparently not
due to a unique composition. The present overview will discuss
recent developments in our understanding of the structure and
macromolecular organization of typical basement membrane
proteins. Most of the progress has been made from studies of
appropriate models, such as basement membrane—producing
tumors [5, 6]. Much evidence indicates that the GBM contains
identical or very similar components to these model systems.
The involvement of the various components in normal GBM
function and in disease is less well understood, but the current
information will be briefly discussed at the end of the article.
Structural models of basement membrane proteins
Basement membranes consist of a unique set of proteins
which form highly integrated supramolecular structures and are
usually not found in other types of extracellular matrices. These
proteins include several components which have an ubiquitous
distribution in basement membranes, as well as other compo-
nents which have a more restricted distribution (Table 1).
Several of these ubiquitous constituents are well characterized
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in terms of their size, polypeptide and/or glycosaminoglycan
chain composition (Table 1) and their shape and domain orga-
nization (Fig. I). Other basement membrane proteins presum-
ably also exist, but have not yet been characterized.
The mechanical stability of basement membranes is thought
to be due to large, insoluble collagen networks built up from
collagen type IV monomers [71. These monomers have a
characteristic shape [8, 23, 24], consisting of a 400 nm long,
rod—like triple helix which terminates at its C-terminal end with
a large (Mr = 85,000) globular domain NCI (Fig. IA). This
structure is very likely formed from two al(IV) chains and one
a2(IV) chain [25] aligned in a parallel fashion. The sequences of
the triple helix and the NC! domain have been largely elucidated
[26, 27]. The data demonstrate many interruptions of the triplet
repeat Gly-X-Y which is characteristic for triple helical collagen
chains. These interruptions endow the collagen 1V triple helix
with higher flexibility than are found for fibril—forming collagens
(types I, 11 and III) and are sites at which the triple helix is
rapidly broken down into large fragments by proteolysis (such
as with pepsin). A metalloproteinase which cleaves a single site
120 nm away from the N-terminal 7S end (Fig. IA) is considered
to initiate collagen IV catabolism in situ [28, 29].
Collagen IV monomers interact with each other in a charac-
teristic fashion during self assembly (Fig. IA). They possess a
60 am long, triple helical 7S domain at their N-terminus, which
is separated from the major triple helix by a long triplet
interruption. These 7S domains associate to form tetramers by
lateral alignment over a 30 nm distance [81. Such tetramers in
tissues, as well as in cell culture, become irreversibly connected
by inter-chain disulfide bonds [23, 24]. A second interaction site
in the globular domain NCI promotes the formation of dimcrs
which are also cross—linked by disulfide bonds [8, 30]. Other
cross—links are also found which are non-reducible in nature
[31]. The sequence in which these interactions occur during
network formation in situ and the final structures formed are not
well characterized, The models proposed are either a loose
meshwork without lateral interaction of molecules along the
major triple helix [8], or a more tightly packed, hexagonal
model. The latter was proposed from reconstitution experi-
ments with collagen IV dimers [321 and implied the alignment of
three to four collagen IV monomers along their entire length.
Laminin [9] is one of the most prominent non-collagenous
glycoproteins found in basement membranes. It consists of a
BI, B2 and A chain which are linked by disulfide bonds to form
a cross—shaped structure [10]. Characteristic features of this
structure are a thread—like long arm terminating into a hep-
arm—binding globular domain, and three, rather similar short
arms consisting of rods and globules (Fig. IB). The arrangement
of chains within this structure is not yet well understood.
Recent data indicates disulfide—bonding between the C-terminal
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Table 1. Molecular and functional properties of basement membrane proteins
Ultracentrifugal
data
Key
Component 520w MrXlO3 Constituent chains Function and special features references
Ubiquitous components
Collagen IV 4.4S 550—600 [al(IV)]2[a2(IV)j about
equal size
large networks, mechanical stability [7, 81
Laminin 1l.5S 1000 Bl, B2 (Mr = 220kD) and
A chain (Mr 400kD) cross—shape, cell—binding [9, 10]
Heparan sulfate proteoglycan HD 4.5S 130 protein core (Mr = 5kD)
four HS chains (Mr
29kD)
filtration control, multiple interactions [11, 121
LD 6.4S 550 protein core (M = 400kD)
three HS chains (Mr
43kD)
Nidogen 6.IS 150 single chain complexes with laminins, other interac-
tions
[13, 14]
Entactin n.d. single chain (Mr = l5SkD) sulfated, related to nidogen [15]
Components with restricted distribution
560 two similar or identical
chains
cell—binding, mainly embryonic BM [16, 17]Fibronectin
Bullous pemphigoid antigen nd, disulfide—linked chains of
Mr = 230kD
only in squamous epithelium, autoantigen [18]
Acetylcholinesterase 17 s globular heads connected
to a collagen tail
synapses of neuromuscular junctions [19]
Amyloid P component 240 ten identical subunits of Mr
= 24kD
some renal BM. cross—linked [201
Thrombospondin 420 three identical chains vessel wall BM, platelets [21, 22]
Abbreviations are: BM, basement membranes; HD, high density form; LD, low density form; HS, heparan sulfate; n.d., not determined.
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Fig. 1. Schematic mode/s of basement poem-
brane collagen IV and it s two modes of asso-
ciation, (A) and of various non—collagenous
1asement membrane proteins, (B). All models
are drawn to the same scale (bar SOnm) and
primarily based on electronmicroscopical and
chemical analysis of collagen IV [8], laminin
[10], low density protcoglycan (LDPG) (M.
Paulsson, J. Engel and R. Timpl,
unpublished), high density proteoglycan
(HDPG) [11] and nidogen [13, 46]. HS denotes
the heparan sulfate side chains of the
proteoglycans and 7S and NCI denote the in-
teracting domains of collagen IV.
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ends of the B! and B2 chains, which then contribute to a 80
nm-long, coiled-coil helix region located in the rod of the long
arm [33, 34]. Other domains of larninin have different
conformational structures, and also differ in composition and
several structural and antigenic properties [35—37].
[36, 371. Neurite outgrowth—promoting activity of laminin is,
however, due to a structure at the end of the long arm [39].
Binding of laminin to cell surfaces is apparently mediated by
specific, integral membrane receptors, which are identified as
68kD proteins in muscle [401 and tumor cells [41]. These
receptors are possibly related to 5'-nucleotidasc bound withinThe major functions of laminin involve its ability to interact
with cells and to modulate cell behaviour [16, 381. The domains plasma membranes (K. von der Mark, personal communica-
of laminin which hind to several normal and tumor cells have tion).
been localized to structures within the short arms of the protein Polyanionic heparan sulfate protcoglycans are also ubiqui-
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tous basement membrane constituents, which were initially
identified in studies of GBMs [42]. When isolated from tumors,
they can be separated into a small, high density form and a
larger, protein—rich low density form (Table I). A structural
model for the high density form [lii indicates a star—like shape
containing four, 30 nm-long heparan sulfate chains (Fig. 1B).
The low density form possesses a 60 nm long, rigid protein core
and three heparan sulfate chains (length 90 nm) connected to
one pole of this core (Fig. 1B). Besides filtration control, these
proteoglycans may be involved in multiple, although weak,
interactions with other basement membrane components, in-
cluding collagen IV and laminin [11]. Immunological studies
showed that these basement membrane proteoglycans are typ-
ical matrix components and differ from cell membrane forms of
heparan sulfate proteoglycans in their localization and anti-
genicity [121. Monoclonal antibody studies [43] have indicated
that basement membranes also contain chondroitin sulfate
proteoglycans as ubiquitous components which, at least in
Reichert's membrane, are of high density [441.
Nidogen was initially isolated as an 8OkD basement mem-
brane protein [13], but later shown to have a genuine size of
l5OkD in tissues [14, 45]. This intact form has a 20 nm-long,
dumbell shaped structure (Fig. 1B), composed of a single
polypeptide chain [46]. Two particular properties of nidogen are
its very high sensitivity to endogenous proteolysis, producing a
defined set of fragments, and also that intact nidogen and the
lOOkD fragment form stable, non-covalent complexes with
laminin, These properties may enable nidogen to modulate
basement membrane structure and function. A sulfated glyco-
protein similar in size to nidogen was originally detected in
biosynthetic studies and named entactin [IS]. Sulfate was
shown to be bound exclusively as a tyrosine ester [44]. Some
other data [44, 451 indicate a close relationship between entactin
and nidogen, but verification of this requires a more compre-
hensive structural characterization of entactin.
Biochemical characterization of GBM proteins
Although GBMs can he purified in reasonable quantities [47]
structural studies on this material have not yet progressed as far
as studies using tumor basement membranes. This is in part due
to a more extensive cross—linking of components within GBM
[48] which prevents extraction of components such as laminin
in a native form. After reduction of disulfide bonds within
isolated GBMs in the presence of detergents, a complex mix-
ture of at least 15 polypeptides could be separated which ranged
in mass from 25kD to 300kD [49]. In addition to immunological
studies, such analyses were useful in demonstrating that GBM
contains all the ubiquitous components identified from tumor
sources.
Initial studies on collagen IV from GBM gave controversial
data, showing that it consisted of a single type of lO8kD chain
alter pepsin treatment similar to interstitial collagens [7], or of
a polydisperse mixture of chains reflecting processing in situ
[50]. Later studies demonstrated larger chain variants after
pepsin treatment [51] which corresponded in size to those
expected for the whole triple helix of collagen IV [81. Fully—
sized collagen TV chains were obtained from OHM after reduc-
tion [52], and were shown to contain a collagenase—resistant
domain resembling the NCI subunits in size. This was con-
firmed recently when native, cross—linked NC! was isolated
from GBM [531. Studies on whole renal tissues demonstrated
the presence of structures containing 1(IV) and 2(lV) chain
fragments in a 2:1 ratio [25], and also tetrameric 7S collagen
[311. Together, these data demonstrate that GBM collagen IV
has a similar structure to and assembles in a similar manner as
collagen IV, which has been more extensively characterized
from tumors (Fig, 1A). However, GBM collagen IV may he
more highly cross—linked by nonreducible bonds [31, 51].
Structural studies of heparan sulfate proteoglycans from
GBM 154, 55] indicate a remarkable similarity to the model for
the high density variant shown in Fig. lB. This GBM compo-
nent has a molecular mass of I 3OkD and consists of an average
of four heparan sulfate chains of 26kD connected to a l8kD
protein core. A GBM proteoglycan containing 70% protein and
heparan sulfate chains of l4kD has recently been characterized
[56] which could correspond to the low density form of the
proteoglycan in tumors. There are also indications that heparan
sulfate proteoglycans of GBM are covalently cross—linked to
collagen IV [48], which has not yet been reported for other
basement membranes. Other studies on GBM proteoglycans or
glycosaminoglycans were entirely based on metabolic labeling
[57—59], and these gave little structural information. Some of
these studies indicated, however, that the predominant glycos-
aminoglycan in GBM is heparan sulfate, with some hyaluronic
acid, while the mesangium produces mainly chondroitin sulfate.
Immunological identification and localization of
GBM components
Identification of additional GBM components have been
entirely based on immunological evidence. They include nido-
gen [45] and entactin (15), which exist in renal extracts as
components of the expected size (I 5OkD) as demonstrated by
immunoblotting. The presence of amyloid P component in
GBM was shown by gel diffusion, and data indicated that most
of it is cross—linked to large molecules [20]. In addition, all of
the ubiquitous basement membrane components have been
identified as constituents of the GBM by immunofluorescent
analysis (Table 1).
A more precise localization of GBM components was at-
tempted in several immunoelectron microscopical studies. The
reports agree on a preferential or exclusive localization of
collagen IV to the lamina densa [60—62], while laminin [61, 63,
641 and proteoglycan [65] appear localized in the lamina rarae.
This localization of proteoglycan correlates with the presence
of negatively charged components in the lamina rara, detected
with cationic probes [2]. Entactin [64], amyloid P component
[201, and the Goodpasture epitope [66] appear to be exclusively
localized in the lamina rara interna. Controversial data exist for
fibronectin, which was found to be in the lamina rara [61], or
lamina densa [621, or absent in GBM [63]. It has also been
argued that fibronectin is merely trapped in the GBM from
serum, rather than being a genuine GBM constituent [671. Other
studies claim that staining for all ubiquitous components is
largely restricted to the lamina densa, with only occasional
projections into the laminae rara [62]. The reasons for these
diverse observations are not clear, but may be due to the
different staining methods used or reflect the quality of the
antibody preparations. It is also probable that several of the
constituents (Fig. 1) span the whole width of GBM and may be
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detectable in different layers of the basement membrane, de-
pending on the domain specificity of the antibodies used.
Ultrastructure
Even though a number of specific molecular interactions are
already known to exist between basement membrane proteins,
little is known about the ultrastructure of GBM at the
supramolecular level. Examination by routine electronmicros-
copy shows a fine network of microfibrils in the lamina densa
and an amorphous appearance of the laminae rarae [21. More
advanced studies [62, 681 demonstrate an anostomosing net-
work of 4 to 5 nm wide cordes in the lamina densa which are
thought to contain laminin at their surface. Plasmin digestion
unmasked an irregular network of fine filaments which con-
tained structures similar to the 7S and NCI domains of collagen
IV. Other morphologically distinct structures consist of rather
complex basotubules and chains of double globules which could
not be equated with any known protein. Such structures were
only occasionally observed in the laminae rarae. The latter
may, however, contain a periodic arrangement (distance 60 nm)
of heparan sulfate proteoglycans, as revealed in studies with
cationic dyes [2, 421.
Molecular basis of function and disease
Most functional studies of the GBM have so far concentrated
on the role of heparan sulfate proteoglycans. Ample evidence
exists [2, 31 that proteoglycans control glomerular filtration by
acting as a charge barrier, but the precise molecular mechanism
is not yet understood. A 33% reduction in proteoglycan content
was found in human diabetic GBM [69], where glomerular
filtration is affected. This was supported in studies on diabetic
animals which showed a decreased synthesis and/or enhanced
degradation of GBM proteoglycan [70—72]. In this context, it
was speculated that a reduction in the amount of proteoglycan
may serve as the signal for increased matrix production, and
may thus initiate a general thickening of the capillary basement
membranes which is observed in diabetes [73].
Further involvement of proteoglycans in pathological situa-
tions is seen in various immune complex diseases, where GBM
proteoglycans may serve as preferred attachment sites for
antigens or immune complexes. Evidence for this possibility
comes from animal studies which showed higher nephritogenic
potential for cationized antigens, or cationic antibody fractions
when compared to neutral or anionic proteins [74—77]. The data
were interpreted to indicate that the net charge of antigens or
antibodies directs immune complex deposition in GBM and
thus determines normal elimination or development of disease.
It is also possible that some antigens bind selectively to
particularly cationic antibodies and thus favour deposition [77].
Binding of immune complexes to proteoglycan sites in GBM
could thus he the direct cause of proteinuria.
Other antibody—mediated nephropathies are due to autoanti-
bodies against GBM structures, as for example in Goodpasture
syndrome. From antibody localization studies, it is concluded
that the Goodpasture epitope is a unique GBM constituent
which is not shared by many other basement membranes [78].
This epitope was recently shown to be present on non-collage-
nous polypeptides of 25kD and 5OkD which could be purified
from collagenase digests of human and bovine GBM [79, 80].
The data also indicated a close relationship to the globular
domain NC1 of collagen IV. This domain has a hexameric
structure when isolated from tissues, which dissociates revers-
ibly into monomers and cross—linked dimers of similar size
when exposed to denaturing agents or acidic pH [30]. Subse-
quent studies confirmed this close relationship and showed that
the epitope is hidden within the NCI hexamer, but becomes
exposed after dissociation [53]. Fractionation studies demon-
strated that only some of the NCI subunits possess the
Goodpasture epitope [81].
The structure of the Goodpasture epitope is not known, but it
could possibly originate from a collagen IV variant which has
not yet been characterized. It is present in low amounts in many
basement membranes [80] and, for example, is also found in
tumor basement membranes [82). The preferential binding of
autoantibodies to renal and lung basement membranes could be
due to a particularly high content of this epitope and may be
facilitated by toxic injuries which exposes this structure [53].
Concluding remarks
Seven to eight years ago, our biochemical knowledge on the
structure of the GBM was restricted to compositional data and
controversial information on the nature of its collagenous
component. This has changed considerably during the past few
years and structural models are now available for several of the
major basement membrane components. Detailed sequence and
conformational analyses may soon become completed for most
of these constituents. It is, however, not known how many
more basement membrane components remain to be discovered
and characterized.
It is likely that only a complete knowledge of the components
will allow us to understand the supramolecular architecture
of basement membranes. Immunoelectron microscopical ap-
proaches to study supramolecular organization have so far
provided mainly conflicting data. In the future, such studies
may become increasingly complemented by molecular interac-
tion studies and reconstitution experiments. Such combined
efforts will eventually lead to a more complete molecular
picture of basement membranes and assist in a better under-
standing of their functions and pathological alterations.
RUPERT TIMPL
Max—Planck—Institute für Biochemie
Federal Republic of Germany
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